Analyst Ratings for TransMedics Group (TMDX)
TMDX Rating Summary
TMDX Price Target Summary
- Highest: $135.00 (Morgan Stanley)
- Lowest: $65.00 (Stifel)
- Average: $103.36
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$103.36 (+46%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$103.36 (+46%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/6/2026 | Barclays | N/A | New Coverage | Overweight (N/A) |
120.00 (N/A) |
82.99 (70.78) |
-14.71% | Details |
| 7/28/2026 | UBS » Updated 8/5/2026 |
Patrick Wood | New Coverage | Neutral (N/A) |
77.00 (80.00) |
74.28 (70.78) |
-4.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
